French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel gemcitabine alone as second-line treatment in metastatic pancreatic cancer patients oleh Amaury Demaziere, Charline Mourgues, Céline Lambert, Sophie Trevis, Hélène Bertucat, Isabelle Grange, Denis Pezet, Valérie Sautou, Marine Jary, Johan Gagnière